Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience
CONCLUSION: Despite notable dosimetric superiority over photon radiotherapy and excellent clinical tolerance, lack of availability of protontherapy facilities limit implementation of mediastinal Hodgkin lymphoma protontherapy. Additionally, strict selection criteria must be defined.PMID:34275748 | DOI:10.1016/j.canrad.2021.06.016
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: P Loap F Goudjil R Dendale Y Kirova Source Type: research
More News: Cancer | Cancer & Oncology | France Health | Hematology | Lymphoma | Psychiatry | Study | USA Health